United States (US) Monogenic Disease Testing Market (2025-2031) | Companies, Share, Analysis, Size & Revenue, Growth, Value, Industry, Trends, Competitive Landscape, Forecast, Outlook, Segmentation

Name: United States (US) Monogenic Disease Testing Market (2025-2031) | Trends & Outlook
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Test Type (Carrier Testing, Diagnostic Testing, New-Born Screening, Predictive and Pre-Symptomatic Testing, Prenatal Testing), By Disease Type (Cystic fibrosis, Sickle Cell Anemia, Severe Combined Immunodeficiency (SCID), Tay-Sachs Disorder, Polycystic Kidney Disorder, Others), By End use (Hospitals, Ambulatory Surgical Centers, Specialized Clinics) And Competitive Landscape

Product Code: ETC9970811	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Shubham Padhi	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Monogenic Disease Testing Market Outlook
Market Size of United States (US) Monogenic Disease Testing Market, 2024
Forecast of United States (US) Monogenic Disease Testing Market, 2031
Historical Data and Forecast of United States (US) Monogenic Disease Testing Revenues & Volume for the Period 2021- 2031
United States (US) Monogenic Disease Testing Market Trend Evolution
United States (US) Monogenic Disease Testing Market Drivers and Challenges
United States (US) Monogenic Disease Testing Price Trends
United States (US) Monogenic Disease Testing Porter's Five Forces
United States (US) Monogenic Disease Testing Industry Life Cycle
Historical Data and Forecast of United States (US) Monogenic Disease Testing Market Revenues & Volume By Test Type for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monogenic Disease Testing Market Revenues & Volume By Carrier Testing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monogenic Disease Testing Market Revenues & Volume By Diagnostic Testing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monogenic Disease Testing Market Revenues & Volume By New-Born Screening for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monogenic Disease Testing Market Revenues & Volume By Predictive and Pre-Symptomatic Testing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monogenic Disease Testing Market Revenues & Volume By Prenatal Testing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monogenic Disease Testing Market Revenues & Volume By Disease Type for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monogenic Disease Testing Market Revenues & Volume By Cystic fibrosis for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monogenic Disease Testing Market Revenues & Volume By Sickle Cell Anemia for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monogenic Disease Testing Market Revenues & Volume By Severe Combined Immunodeficiency (SCID) for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monogenic Disease Testing Market Revenues & Volume By Tay-Sachs Disorder for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monogenic Disease Testing Market Revenues & Volume By Polycystic Kidney Disorder for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monogenic Disease Testing Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monogenic Disease Testing Market Revenues & Volume By End use for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monogenic Disease Testing Market Revenues & Volume By Hospitals for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monogenic Disease Testing Market Revenues & Volume By Ambulatory Surgical Centers for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monogenic Disease Testing Market Revenues & Volume By Specialized Clinics for the Period 2021- 2031
United States (US) Monogenic Disease Testing Import Export Trade Statistics
Market Opportunity Assessment By Test Type
Market Opportunity Assessment By Disease Type
Market Opportunity Assessment By End use
United States (US) Monogenic Disease Testing Top Companies Market Share
United States (US) Monogenic Disease Testing Competitive Benchmarking By Technical and Operational Parameters
United States (US) Monogenic Disease Testing Company Profiles
United States (US) Monogenic Disease Testing Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Monogenic Disease Testing Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Monogenic Disease Testing Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Monogenic Disease Testing Market - Industry Life Cycle

3.4 United States (US) Monogenic Disease Testing Market - Porter's Five Forces

3.5 United States (US) Monogenic Disease Testing Market Revenues & Volume Share, By Test Type, 2021 & 2031F

3.6 United States (US) Monogenic Disease Testing Market Revenues & Volume Share, By Disease Type, 2021 & 2031F

3.7 United States (US) Monogenic Disease Testing Market Revenues & Volume Share, By End use, 2021 & 2031F

4 United States (US) Monogenic Disease Testing Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of monogenic diseases in the United States

4.2.2 Technological advancements in genetic testing leading to better accuracy and affordability

4.2.3 Growing awareness and adoption of personalized medicine in healthcare

4.3 Market Restraints

4.3.1 High cost associated with monogenic disease testing

4.3.2 Limited reimbursement policies for genetic testing services

4.3.3 Ethical and privacy concerns related to genetic testing

5 United States (US) Monogenic Disease Testing Market Trends

6 United States (US) Monogenic Disease Testing Market, By Types

6.1 United States (US) Monogenic Disease Testing Market, By Test Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Monogenic Disease Testing Market Revenues & Volume, By Test Type, 2021- 2031F

6.1.3 United States (US) Monogenic Disease Testing Market Revenues & Volume, By Carrier Testing, 2021- 2031F

6.1.4 United States (US) Monogenic Disease Testing Market Revenues & Volume, By Diagnostic Testing, 2021- 2031F

6.1.5 United States (US) Monogenic Disease Testing Market Revenues & Volume, By New-Born Screening, 2021- 2031F

6.1.6 United States (US) Monogenic Disease Testing Market Revenues & Volume, By Predictive and Pre-Symptomatic Testing, 2021- 2031F

6.1.7 United States (US) Monogenic Disease Testing Market Revenues & Volume, By Prenatal Testing, 2021- 2031F

6.2 United States (US) Monogenic Disease Testing Market, By Disease Type

6.2.1 Overview and Analysis

6.2.2 United States (US) Monogenic Disease Testing Market Revenues & Volume, By Cystic fibrosis, 2021- 2031F

6.2.3 United States (US) Monogenic Disease Testing Market Revenues & Volume, By Sickle Cell Anemia, 2021- 2031F

6.2.4 United States (US) Monogenic Disease Testing Market Revenues & Volume, By Severe Combined Immunodeficiency (SCID), 2021- 2031F

6.2.5 United States (US) Monogenic Disease Testing Market Revenues & Volume, By Tay-Sachs Disorder, 2021- 2031F

6.2.6 United States (US) Monogenic Disease Testing Market Revenues & Volume, By Polycystic Kidney Disorder, 2021- 2031F

6.2.7 United States (US) Monogenic Disease Testing Market Revenues & Volume, By Others, 2021- 2031F

6.3 United States (US) Monogenic Disease Testing Market, By End use

6.3.1 Overview and Analysis

6.3.2 United States (US) Monogenic Disease Testing Market Revenues & Volume, By Hospitals, 2021- 2031F

6.3.3 United States (US) Monogenic Disease Testing Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F

6.3.4 United States (US) Monogenic Disease Testing Market Revenues & Volume, By Specialized Clinics, 2021- 2031F

7 United States (US) Monogenic Disease Testing Market Import-Export Trade Statistics

7.1 United States (US) Monogenic Disease Testing Market Export to Major Countries

7.2 United States (US) Monogenic Disease Testing Market Imports from Major Countries

8 United States (US) Monogenic Disease Testing Market Key Performance Indicators

8.1 Number of new genetic tests developed and approved for monogenic diseases

8.2 Adoption rate of genetic testing for monogenic diseases by healthcare providers

8.3 Research and development investment in genetic testing technologies for monogenic diseases

9 United States (US) Monogenic Disease Testing Market - Opportunity Assessment

9.1 United States (US) Monogenic Disease Testing Market Opportunity Assessment, By Test Type, 2021 & 2031F

9.2 United States (US) Monogenic Disease Testing Market Opportunity Assessment, By Disease Type, 2021 & 2031F

9.3 United States (US) Monogenic Disease Testing Market Opportunity Assessment, By End use, 2021 & 2031F

10 United States (US) Monogenic Disease Testing Market - Competitive Landscape

10.1 United States (US) Monogenic Disease Testing Market Revenue Share, By Companies, 2024

10.2 United States (US) Monogenic Disease Testing Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Monogenic Disease Testing Market

Equatorial Guinea Monogenic Disease Testing Market

Estonia Monogenic Disease Testing Market

Ethiopia Monogenic Disease Testing Market

Fiji Monogenic Disease Testing Market

Finland Monogenic Disease Testing Market

Global Monogenic Disease Testing Market

Middle East Monogenic Disease Testing Market

North America Monogenic Disease Testing Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here